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  Abstract	  	  Dementia	  is	  a	  syndrome	  associated	  with	  declining	  cognitive	  function	  that	  has	  a	  variety	  of	  types	  and	  causes,	  and	  is	  encountered	  frequently	  in	  general	  medical	  practice.	  Researchers	  are	  actively	  exploring	  possible	  risk	  factors	  for	  dementia.	  The	  St.	  Louis	  University	  Mental	  Status	  (SLUMS)	  exam	  is	  a	  dementia-­‐screening	  exam	  used	  in	  primary	  care	  visits	  to	  detect	  cognitive	  impairment	  that	  may	  be	  a	  sign	  of	  dementia.	  This	  study	  compared	  scores	  on	  the	  SLUMS	  exam	  to	  other	  measures	  recorded	  in	  a	  typical	  primary	  care	  visit	  in	  86	  patients	  of	  age	  65	  and	  older	  to	  look	  for	  correlations	  between	  indicators	  of	  health,	  such	  as	  physical	  examination	  measures	  and	  complete	  blood	  count	  panels,	  and	  cognitive	  impairment,	  as	  measured	  by	  score	  on	  the	  SLUMS	  exam.	  Abnormal	  gait	  was	  associated	  with	  a	  lower	  score	  on	  the	  SLUMS	  exam	  compared	  to	  normal	  (p=.006),	  failure	  of	  the	  hearing	  test	  in	  both	  ears	  was	  associated	  with	  a	  lower	  score	  on	  the	  SLUMS	  exam	  compared	  to	  patients	  passing	  the	  hearing	  test	  in	  one	  or	  both	  ears	  (p=.046),	  red	  blood	  cell	  count	  was	  positively	  correlated	  with	  SLUMS	  exam	  score	  (p=.020),	  white	  blood	  cell	  count	  was	  negatively	  correlated	  with	  SLUMS	  exam	  score	  (p=.003),	  and	  serum	  albumin	  levels	  were	  negatively	  correlated	  with	  SLUMS	  exam	  score	  (p=.002).	  These	  data	  support	  the	  view	  that	  both	  physical	  impairments	  and	  markers	  of	  an	  inflammatory	  response	  are	  related	  to	  dementia.	  	  	   Keywords:	  dementia,	  cognitive	  impairment,	  inflammation,	  hearing,	  gait,	  albumin,	  white	  blood	  cells,	  red	  blood	  cells	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Introduction	  Dementia	  is	  estimated	  to	  affect	  14.7%	  of	  the	  US	  population	  aged	  70	  years	  and	  older,	  and	  to	  cost	  an	  estimated	  $159	  billion	  to	  $215	  billion	  nationwide	  (Hurd,	  Martorell,	  Delvande,	  Mullen	  and	  Langa,	  2013).	  	  Worldwide,	  nearly	  35.6	  million	  people	  live	  with	  dementia,	  a	  number	  that	  is	  expected	  to	  triple	  by	  2050	  (World	  Health	  Association).	  Primary	  care	  visits	  frequently	  use	  screening	  tools	  such	  as	  the	  Mini-­‐Mental	  Status	  Exam	  (MMSE)	  or	  St.	  Louis	  University	  Mental	  Status	  (SLUMS)	  exam	  to	  assess	  cognitive	  impairment	  and	  screen	  for	  dementia	  in	  elderly	  patients.	  An	  advantage	  of	  the	  SLUMS	  exam	  is	  that	  it	  differentiates	  dementia	  from	  mild	  neurocognitive	  impairment	  (MNCI),	  which	  may	  precede	  dementia	  in	  younger	  patients,	  so	  it	  has	  a	  broader	  assessment	  of	  cognitive	  impairment	  (Tariq,	  Tumosa,	  Chibnall,	  Perry	  and	  Morley,	  2006).	  In	  order	  to	  consider	  physical	  and	  biological	  factors	  associated	  with	  cognitive	  impairment,	  this	  study	  analyzed	  primary-­‐care	  health	  measures	  to	  find	  associations	  to	  scores	  on	  the	  SLUMS	  screening	  exam.	  The	  five	  variables	  that	  were	  selected	  for	  analysis	  were	  hearing,	  abnormal	  gait,	  white	  blood	  cell	  count,	  serum	  albumin	  levels,	  and	  red	  blood	  cell	  count.	  It	  is	  hypothesized	  that	  results	  from	  this	  study	  will	  find	  associations	  with	  these	  variables	  to	  SLUMS	  exam	  score	  that	  are	  support	  evidence	  of	  associations	  of	  the	  variables	  to	  scores	  on	  the	  MMSE	  and	  clinical	  diagnoses.	  	  
Vascular	  Risk	  Factors	  Hypertension,	  dyslipidemia,	  and	  diabetes	  have	  been	  shown	  to	  increase	  risk	  for	  both	  vascular	  dementia	  and	  Alzheimer's	  disease	  (Kloppenborg,	  van	  den	  Berg,	  Kappelle,	  and	  Biessels,	  2008).	  These	  factors	  frequently	  occur	  together	  in	  what	  is	  known	  as	  the	  “metabolic	  syndrome.”	  However,	  these	  variables	  were	  not	  considered	  in	  this	  analysis,	  as	  the	  data	  collected	  came	  from	  patients	  under	  a	  physician’s	  care,	  whose	  hypertension,	  dyslipidemia,	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  and	  diabetes	  were	  actively	  controlled	  for	  by	  medications	  that	  may	  lower	  blood	  pressure,	  cholesterol,	  and	  blood	  glucose.	  Launer	  et	  al.	  (2000)	  found	  that	  blood	  pressure	  showed	  no	  association	  with	  dementia	  risk	  in	  men	  treated	  with	  anti-­‐hypertensive	  medications.	  Therefore,	  it	  is	  predicted	  that	  there	  will	  be	  no	  association	  in	  this	  study	  due	  to	  effects	  of	  medications.	  	  
Hearing	  Hearing	  loss	  has	  been	  shown	  to	  be	  more	  prevalent	  in	  populations	  with	  dementia,	  and	  to	  correlate	  with	  greater	  cognitive	  impairment	  as	  measured	  by	  the	  MMSE	  in	  both	  groups	  with	  and	  without	  dementia	  (Uhlmann,	  Larson,	  Rees,	  Koepsell	  and	  Duckert,	  1989).	  Lin	  et	  al.	  (2011)	  performed	  a	  longitudinal	  study	  using	  data	  from	  the	  Baltimore	  Longitudinal	  Study	  of	  Aging,	  and	  found	  that	  during	  a	  median	  follow-­‐up	  of	  11.9	  years,	  the	  risk	  of	  all-­‐cause	  dementia	  increased	  with	  greater	  baseline	  hearing	  loss.	  	  Uhlmann,	  et	  al.	  hypothesize	  that	  hearing	  loss	  may	  be	  a	  risk	  factor	  to	  target	  for	  dementia	  prevention,	  as	  hearing	  loss	  decreases	  stimuli	  from	  the	  environment	  processed	  in	  the	  brain,	  and	  may	  also	  affect	  an	  individual’s	  social	  interactions,	  possibly	  leading	  to	  social	  isolation.	  	  Another	  explanation	  is	  that	  the	  pathology	  that	  affects	  dementia	  may	  also	  affect	  cortical	  structures	  that	  process	  auditory	  stimuli.	  However,	  Uhlmann,	  et	  al.	  observed	  a	  relationship	  between	  hearing	  loss	  and	  cognitive	  impairment	  that	  was	  independent	  of	  age,	  which	  would	  not	  be	  expected	  for	  an	  age-­‐related	  neurodegeneration	  process.	  	  Lin	  et	  al.	  (2011)	  found	  hearing	  loss	  to	  be	  prospectively	  related	  to	  dementia.	  In	  this	  study,	  risk	  of	  dementia	  was	  only	  associated	  with	  hearing	  loss	  at	  thresholds	  greater	  than	  25	  dB,	  which	  is	  the	  threshold	  determined	  at	  which	  hearing	  loss	  will	  begin	  to	  impair	  verbal	  conversation	  (Lin	  et	  al.,	  2011),	  suggesting	  the	  importance	  of	  social	  interaction	  and	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  environmental	  enrichment	  in	  maintaining	  intact	  cognitive	  function.	  As	  hearing	  loss	  in	  both	  ears	  is	  much	  more	  functionally	  disabling,	  this	  study	  will	  compare	  hearing	  loss	  in	  both	  ears	  to	  intact	  hearing	  in	  one	  or	  both	  ears	  to	  determine	  if	  there	  is	  an	  association	  to	  cognitive	  impairment	  according	  to	  score	  on	  the	  SLUMS	  screening	  exam.	  	  It	  is	  predicted	  that	  hearing	  loss	  in	  both	  ears	  will	  have	  a	  lower	  score	  on	  the	  SLUMS	  screening	  exam	  than	  intact	  hearing	  in	  one	  or	  both	  ears.	  	  
Gait	   Recent	  studies	  suggest	  abnormal	  gait	  to	  be	  a	  predictor	  of	  non-­‐Alzheimer's	  dementia.	  Verghese	  et	  al.	  (2002)	  used	  data	  from	  the	  Bronx	  Aging	  Study	  to	  compare	  dementia	  diagnoses	  for	  subjects	  with	  neurologic	  gait	  abnormalities	  to	  patients	  whose	  gait	  was	  normal	  after	  a	  median	  follow-­‐up	  period	  of	  6.6	  years.	  Verghese	  et	  al.	  found	  that	  subjects	  with	  abnormal	  gaits	  were	  more	  likely	  to	  have	  non-­‐Alzheimer’s	  dementia,	  but	  not	  more	  likely	  to	  have	  Alzheimer’s	  disease.	  Diagnoses	  were	  made	  by	  clinical	  and	  neuropsychological	  evaluations	  and	  confirmed	  by	  postmortem	  examinations	  in	  the	  14.5	  percent	  of	  subjects	  who	  died.	  It	  is	  hypothesized	  that	  gait	  disturbances	  are	  an	  effect	  of	  lesions	  in	  the	  brain	  related	  to	  vascular	  dementia	  that	  precede	  the	  appearance	  of	  cognitive	  decline	  (Hennerici	  et	  al.,	  1994).	  	  	  Other	  studies	  have	  used	  quantitative	  gait	  analysis	  to	  look	  at	  different	  factors	  of	  gait	  such	  as	  speed,	  variability,	  and	  trunk	  accelerations.	  Patients	  with	  dementia	  show	  a	  slower	  walking	  speed,	  greater	  stride	  time	  and	  stride	  time	  variability,	  and	  more	  irregular	  trunk	  accelerations	  than	  both	  older	  and	  younger	  cognitively	  intact	  controls	  (Ijmker	  	  and	  Lamoth,	  2012).	  Ijmker	  and	  Lamoth	  suggest	  that	  considering	  these	  patterns	  may	  provide	  an	  additional	  tool	  for	  early	  diagnosis	  of	  dementia.	  Due	  to	  a	  small	  sample,	  this	  study	  will	  only	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  gait	  as	  abnormal	  versus	  normal	  in	  comparing	  scores	  on	  the	  SLUMS	  screening	  exam.	  	  It	  is	  predicted	  that	  abnormal	  gait	  will	  be	  associated	  with	  lower	  scores	  on	  the	  SLUMS	  screening	  exam.	  	  
Inflammation	  Inflammation	  is	  commonly	  studied	  by	  measuring	  levels	  of	  inflammatory	  proteins	  in	  blood	  plasma	  such	  as	  c-­‐reactive	  protein	  (CRP)	  and	  interleukin-­‐6	  (IL-­‐6).	  IL-­‐6	  is	  a	  pro-­‐inflammatory	  cytokine,	  and	  CRP	  is	  a	  positive	  acute	  phase	  protein.	  Inflammation	  is	  associated	  with	  an	  increased	  risk	  for	  cardiovascular	  disease,	  and	  moderately	  high	  IL-­‐6	  and	  CRP	  levels	  have	  been	  associated	  to	  increased	  mortality	  in	  the	  elderly	  (Harris,	  et	  al.,	  1999).	  High	  levels	  of	  IL-­‐6	  are	  also	  shown	  to	  be	  associated	  with	  an	  increased	  risk	  of	  non-­‐Alzheimer's	  dementia	  (Sundelöf	  et	  al.,	  2009),	  likely	  due	  to	  cardiovascular	  disease	  mechanisms	  leading	  to	  vascular	  dementia.	  IL-­‐6	  is	  known	  to	  cross	  the	  blood-­‐brain	  barrier	  to	  modulate	  immune	  and	  inflammatory	  responses	  that	  may	  result	  in	  neurodegeneration.	  Chronic	  increases	  in	  peripheral	  inflammation	  increase	  central	  inflammatory	  responses	  in	  the	  brain,	  which	  are	  hypothesized	  to	  drive	  chronic	  neurodegeneration	  (Perry,	  Cunningham	  and	  Holmes,	  2007).	  	  	  Marsland	  et	  al.	  (2014)	  found	  IL-­‐6	  and	  CRP	  were	  higher	  in	  subjects	  with	  decreased	  cognitive	  function	  in	  the	  areas	  of	  spatial	  reasoning,	  short	  term	  memory,	  verbal	  proficiency,	  learning	  and	  memory,	  and	  executive	  function,	  and	  that	  higher	  levels	  of	  IL-­‐6	  and	  CRP	  were	  also	  associated	  with	  lower	  cortical	  gray	  and	  white	  matter	  volumes	  according	  to	  MRI	  volumetric	  measurements,	  while	  controlling	  for	  age,	  sex,	  race,	  education,	  BMI	  and	  nicotine	  and	  alcohol	  use.	  This	  study	  suggests	  that	  inflammation	  may	  accelerate	  cognitive	  decline	  by	  affecting	  brain	  morphology.	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  As	  blood	  tests	  for	  IL-­‐6	  and	  CRP	  are	  not	  typically	  performed	  in	  primary-­‐care	  visits,	  this	  study	  will	  examine	  if	  white	  blood	  cell	  count	  and	  serum	  albumin	  levels	  can	  predict	  inflammation	  associated	  with	  cognitive	  decline.	  	  
White	  Blood	  Cell	  Count	  
	   The	  American	  Heart	  Association	  lists	  white	  blood	  cell	  count	  as	  an	  inflammatory	  maker	  that	  is	  a	  potential	  predictor	  of	  cardiovascular	  risk,	  although	  they	  recommend	  high-­‐sensitivity	  C-­‐reactive	  protein	  as	  having	  the	  greatest	  utility	  (Pearson,	  et	  al.,	  2003).	  White	  blood	  cell	  count	  is	  also	  indicated	  as	  an	  independent	  predictor	  of	  cardiovascular	  disease	  events,	  stroke	  and	  all-­‐cause	  mortality	  in	  women	  and	  was	  found	  to	  be	  a	  comparable	  assessor	  of	  cardiovascular	  risk	  as	  CRP	  (Margolis,	  et	  al.,	  2005).	  As	  vascular	  risk	  factors	  and	  stroke	  increase	  the	  risk	  for	  development	  of	  vascular	  dementia,	  (Ross	  et	  al.,	  1999),	  it	  is	  likely	  that	  white	  blood	  cell	  count	  can	  also	  predict	  vascular	  dementia	  risk.	  	  Shad,	  Aghazadeh,	  Ahmad	  and	  Kress	  (2013)	  found	  that	  blood	  levels	  of	  monocytes	  and	  neutrophils	  are	  elevated	  above	  the	  normal	  range	  in	  patients	  diagnosed	  with	  Alzheimer’s	  disease,	  irrespective	  of	  patient	  age	  and	  sex,	  and	  suggest	  that	  white	  blood	  cells	  may	  serve	  as	  key	  peripheral	  markers	  for	  early	  diagnosis	  of	  Alzheimer’s	  disease.	  It	  is	  predicted	  in	  this	  study	  that	  higher	  white	  blood	  cell	  counts	  will	  be	  correlated	  to	  lower	  scores	  on	  the	  SLUMS	  screening	  exam.	  
Serum	  Albumin	  Levels	  	  Serum	  albumin	  is	  a	  negative	  acute	  phase	  protein	  that	  decreases	  in	  serum	  level	  as	  inflammation	  and	  positive	  acute	  phase	  proteins,	  such	  as	  CRP,	  increase.	  In	  a	  previous	  study,	  serum	  albumin	  level	  was	  shown	  to	  correlate	  with	  scores	  on	  the	  MMSE	  (Dik,	  et	  al.,	  2005).	  However,	  these	  results	  were	  somewhat	  inconclusive,	  as	  the	  association	  lost	  significance	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  after	  adjustment	  for	  age.	  Dik	  et	  al.	  also	  did	  not	  find	  any	  association	  between	  Il-­‐6	  and	  MMSE	  score	  or	  CRP	  and	  MMSE	  score,	  which	  disagrees	  with	  the	  findings	  of	  several	  other	  studies	  (Teunissen	  et	  al.,	  	  2003),	  (Marsland	  et	  al.,	  2014).	  	  A	  major	  limitation	  of	  the	  Dik	  et	  al.	  study	  was	  also	  nonresponse	  and	  loss	  of	  follow-­‐up,	  which	  may	  have	  accounted	  for	  lost	  associations	  because	  of	  selective	  loss	  to	  follow-­‐up.	  	  More	  recent	  studies	  have	  found	  further	  evidence	  of	  a	  possible	  relationship	  between	  serum	  albumin	  levels	  and	  amount	  of	  cognitive	  decline.	  Ng,	  Niti,	  Feng,	  Kua	  	  and	  Yap	  (2009)	  found	  low	  serum	  albumin	  levels	  to	  be	  associated	  to	  cognitive	  impairment	  and	  decline	  in	  a	  population	  of	  2,	  611	  elderly	  Chinese	  from	  the	  Singapore	  Longitudinal	  Aging	  Study.	  The	  Ng	  et	  al.	  study	  also	  found	  an	  association	  between	  low	  albumin	  levels	  and	  cognitive	  decline	  to	  be	  especially	  strong	  in	  individuals	  with	  the	  APOE-­‐4	  genotype,	  suggesting	  a	  genetic	  vulnerability.	  	  Low	  albumin	  levels	  was	  found	  to	  be	  an	  independent	  risk	  marker	  for	  cognitive	  decline,	  as	  defined	  by	  a	  decrease	  in	  3	  points	  on	  the	  MMSE	  in	  a	  population	  of	  873	  Japanese	  aged	  70	  and	  older	  (Taniguchi	  et	  al.,	  2014).	  	  The	  Taniguchi	  et	  al.	  study	  and	  the	  Ng	  et	  al.	  study	  also	  emphasize	  the	  role	  of	  serum	  albumin	  in	  nutrition.	  As	  albumin	  can	  be	  consumed	  through	  dietary	  proteins,	  there	  is	  the	  potential	  to	  explore	  the	  effects	  of	  protein	  supplementation	  on	  cognitive	  effects	  in	  the	  elderly.	  	  It	  is	  predicted	  in	  this	  study	  that	  low	  serum	  albumin	  levels	  will	  be	  associated	  with	  a	  lower	  score	  on	  the	  SLUMS	  screening	  exam.	  	  
Red	  Blood	  Cell	  Count	  	  Taniguchi	  et	  al.	  (2014)	  was	  the	  first	  study	  to	  show	  that	  red	  blood	  cell	  count	  was	  an	  independent	  predictor	  for	  cognitive	  decline	  on	  the	  MMSE	  after	  adjusting	  for	  confounders.	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  Taniguchi	  et	  al.	  suggest	  that	  this	  may	  be	  mediated	  by	  nutrition;	  for	  example	  low	  iron	  intake	  leads	  to	  smaller	  red	  blood	  cells.	  In	  addition,	  nutritional	  intake	  is	  related	  to	  albumin	  levels	  in	  the	  blood,	  which	  Taniguchi	  et	  al.	  also	  found	  to	  be	  related	  to	  cognitive	  decline	  in	  the	  same	  study.	  Low	  nutritional	  status	  is	  also	  related	  to	  frailty	  and	  low	  body	  weight.	  Qizilbasch	  et	  al.	  (2015)	  recently	  found	  in	  a	  retrospective	  cohort	  study	  of	  two	  million	  subjects	  that	  underweight	  people	  (BMI	  <20	  kg/m2)	  had	  a	  34	  percent	  higher	  risk	  of	  dementia	  than	  those	  of	  a	  healthy	  weight,	  and	  very	  obese	  people	  (BMI>40	  kg/m2)	  had	  a	  29	  percent	  higher	  risk	  of	  dementia	  than	  those	  of	  a	  healthy	  weight.	  Although	  these	  results	  do	  not	  support	  previous	  studies	  of	  Body	  Mass	  Index	  (BMI)	  predicting	  dementia	  risk,	  they	  do	  suggest	  that	  nutritional	  status	  may	  play	  a	  very	  important	  role	  in	  cognitive	  decline,	  and	  red	  blood	  cell	  count	  is	  a	  possible	  way	  to	  predict	  relevant	  nutrition.	  It	  is	  predicted	  in	  this	  study	  that	  low	  red	  blood	  cell	  count	  will	  be	  associated	  with	  a	  low	  score	  on	  the	  SLUMS	  exam.	  	  
The	  Current	  Study	  
	   This	  study	  is	  designed	  to	  extend	  the	  current	  research	  on	  dementia	  by	  analyzing	  several	  possible	  contributing	  variables	  to	  cognitive	  impairment	  in	  the	  same	  population.	  This	  study	  will	  use	  the	  SLUMS	  screening	  exam	  to	  estimate	  level	  of	  cognitive	  impairment.	  The	  goal	  of	  this	  study	  is	  to	  better	  understand	  what	  other	  markers	  regularly	  measured	  in	  a	  primary	  care	  visit	  are	  associated	  with	  cognitive	  impairment,	  so	  that	  a	  more	  complete	  diagnostic	  picture	  for	  dementia	  can	  be	  formed	  that	  includes	  considering	  cognitive	  testing,	  physical	  examination	  and	  biomarkers	  from	  blood	  work.	  Previous	  studies	  have	  found	  associations	  of	  hearing,	  gait,	  white	  blood	  cell	  count,	  serum	  albumin,	  and	  red	  blood	  cell	  counts	  to	  either	  the	  MMSE	  or	  clinical	  diagnoses,	  but	  not	  the	  SLUMS	  exam,	  which	  provides	  a	  broader	  and	  more	  detailed	  assessment	  of	  cognitive	  impairment.	  It	  is	  hypothesized	  that	  the	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  SLUMS	  exam	  will	  follow	  the	  same	  patterns	  of	  association	  to	  hearing,	  gait,	  white	  blood	  cell	  count,	  serum	  albumin,	  and	  red	  blood	  cell	  counts	  as	  previous	  studies	  that	  use	  the	  MMSE	  or	  clinical	  diagnoses,	  as	  described	  in	  the	  above	  sections.	  
Methods	  
Participants	  
	  Archival	  data	  were	  collected	  from	  electronic	  medical	  records	  at	  Goodwin	  Community	  Health,	  Somersworth,	  NH.	  A	  report	  was	  generated	  for	  all	  patients	  65	  and	  older	  with	  a	  score	  on	  the	  SLUMS	  exam,	  N=86.	  Data	  for	  SLUMS	  scores	  and	  other	  measures	  were	  transferred	  to	  a	  de-­‐identified	  data	  file.	  Approval	  was	  given	  from	  the	  University	  of	  New	  Hampshire	  Institutional	  Review	  Board	  for	  the	  Protection	  of	  Human	  Subjects	  in	  Research	  (IRB)	  and	  the	  Chief	  Information	  Officer	  at	  Goodwin	  Community	  Health.	  A	  HIPAA	  privacy	  regulation	  waiver	  was	  obtained.	  Mean	  age	  of	  the	  participants	  was	  70.74	  years	  and	  subjects	  were	  primarily	  white.	  There	  were	  significantly	  more	  females	  (N=71)	  than	  males	  (N=15).	  Table	  1	  	  
Sample	  Demographics	  	  
	   Males	   Females	  
N	   15	   71	  
Mean	  SLUMS	  Score	   23.4	   24.6	  
Mean	  Age	   70.5	   70.8	  
Mean	  BMI	   29.3	   31.0	  
Mean	  Blood	  Pressure	   127/73	   126/70	  
Mean	  Cholesterol	   173.5	   200.4	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Measures	  The	  six	  variables	  analyzed	  were	  SLUMS	  exam	  score,	  hearing,	  gait,	  white	  blood	  cell	  count,	  serum	  albumin	  level	  and	  red	  blood	  cell	  count.	  The	  SLUMS	  exam	  has	  a	  score	  from	  0-­‐30,	  with	  scores	  from	  1-­‐20	  indicating	  dementia	  (N=17),	  21-­‐26	  indicating	  mild	  neurocognitive	  impairment	  (N=32),	  and	  27-­‐30	  indicating	  normal	  cognitive	  function	  (N=37).	  Scoring	  assumed	  that	  all	  patients	  had	  a	  high	  school	  education.	  The	  mean	  SLUMS	  was	  24.35,	  SD=5.09.	  	  
	  Figure	  1:	  Frequency	  of	  SLUMS	  scores	  and	  frequency	  of	  the	  three	  indications.	  	  Hearing	  loss	  was	  measured	  by	  a	  hearing	  test	  of	  each	  ear,	  with	  the	  possibility	  to	  pass	  or	  fail	  the	  test.	  Data	  from	  patients	  with	  a	  hearing	  aid	  were	  not	  included.	  	  Hearing	  data	  were	  available	  for	  45	  patients.	  If	  a	  patient	  passed	  the	  test	  in	  one	  or	  both	  ears,	  the	  patient	  was	  placed	  into	  the	  some	  hearing	  group	  (N=14).	  If	  a	  patient	  failed	  the	  test	  in	  both	  ears,	  the	  patient	  was	  placed	  into	  the	  hearing	  loss	  in	  both	  ears	  group	  (N=31).	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  Gait	  was	  determined	  by	  the	  patient's	  provider	  and	  documented	  by	  the	  physician’s	  comments	  in	  the	  chart.	  Gait	  data	  was	  available	  for	  71	  patients.	  Patients	  described	  as	  normal	  gait	  were	  placed	  in	  the	  normal	  gait	  group	  (N=60).	  Any	  gait	  that	  was	  not	  described	  as	  normal	  was	  placed	  in	  the	  abnormal	  gait	  group	  (N=11).	  	  	  White	  blood	  cell	  count	  (M=7.09,	  SD=2.03),	  serum	  albumin	  level	  (M=4.19,	  SD=0.47),	  and	  red	  blood	  cell	  count	  (M=4.47,	  SD=0.45)	  were	  all	  measured	  by	  routine	  blood	  tests.	  Statistical	  analysis	  was	  performed	  using	  SPSS.	  	  	  
Results	  
Hearing	  
	   To	  evaluate	  whether	  SLUMS	  score	  differed	  between	  groups	  with	  hearing	  loss	  in	  both	  ears	  and	  no	  hearing	  loss	  or	  loss	  in	  one	  ear,	  an	  independent	  samples	  t-­‐test	  was	  performed.	  SLUMS	  scores	  were	  approximately	  normally	  distributed	  with	  no	  extreme	  outliers.	  The	  group	  with	  hearing	  loss	  in	  both	  ears	  had	  a	  significantly	  lower	  SLUMS	  score	  (M=22.26,	  SD=5.38)	  than	  the	  group	  with	  no	  hearing	  loss	  or	  hearing	  loss	  in	  one	  ear	  (M=25.43,	  SD=3.03).	  t(43)=2.055,	  p=.046,	  two-­‐tailed.	  This	  was	  approximately	  a	  3	  point	  difference	  on	  the	  SLUMS	  score	  between	  the	  two	  hearing	  groups,	  a	  difference	  large	  enough	  to	  have	  clinical	  significance.	  Eta-­‐squared=0.09,	  which	  corresponds	  to	  a	  small	  effect	  size.	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  Figure	  2:	  Mean	  SLUMS	  scores	  for	  the	  two	  hearing	  groups.	  	  	  
Gait	   To	  evaluate	  whether	  SLUMS	  score	  differed	  between	  the	  group	  with	  normal	  gait	  and	  the	  group	  with	  abnormal	  gait,	  an	  independent	  samples	  t-­‐test	  was	  performed.	  SLUMS	  scores	  were	  approximately	  normally	  distributed	  with	  no	  extreme	  outliers.	  	  The	  group	  with	  abnormal	  gait	  had	  a	  significantly	  lower	  SLUMS	  score	  (M=20.45,	  SD=6.76)	  than	  the	  group	  with	  normal	  gait(M=24.87,	  SD=4.34).	  t(69)=2.82,	  p=.006,	  two-­‐tailed.	  This	  was	  approximately	  a	  4.4	  point	  difference	  on	  the	  SLUMS	  score	  between	  the	  two	  gait	  groups,	  a	  difference	  large	  enough	  to	  have	  clinical	  significance	  Eta-­‐squared=0.1,	  which	  corresponds	  to	  a	  small	  effect	  size.	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  Figure	  3:	  Mean	  SLUMS	  scores	  for	  the	  abnormal	  and	  normal	  gait	  groups.	  	  
White	  Blood	  Cell	  Count	  
	   To	  evaluate	  whether	  SLUMS	  score	  could	  be	  predicted	  by	  white	  blood	  cell	  count,	  a	  bivariate	  linear	  regression	  analysis	  was	  performed.	  Scores	  for	  both	  the	  SLUMS	  score	  and	  white	  blood	  cell	  count	  (white	  blood	  cells	  per	  liter)	  were	  approximately	  normally	  distributed	  with	  no	  extreme	  outliers.	  A	  scatter	  plot	  indicated	  the	  relation	  between	  X	  and	  Y	  was	  negative	  and	  there	  were	  no	  extreme	  bivariate	  outliers.	  The	  regression	  was	  statistically	  significant,	  r=.331,	  r2=.110,	  F(76)=9.234,	  p=.003.	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  Figure	  4:	  SLUMS	  score	  is	  negatively	  correlated	  to	  white	  blood	  cell	  count.	  	  	  
Serum	  Albumin	  Level	  
	   To	  evaluate	  whether	  SLUMS	  score	  could	  be	  predicted	  by	  serum	  albumin	  level,	  a	  bivariate	  linear	  regression	  analysis	  was	  performed.	  Scores	  for	  both	  the	  SLUMS	  score	  and	  serum	  albumin	  level	  (mg/dl)	  were	  approximately	  normally	  distributed	  with	  no	  extreme	  outliers.	  A	  scatter	  plot	  indicated	  the	  relation	  between	  X	  and	  Y	  was	  negative	  and	  there	  were	  no	  extreme	  bivariate	  outliers.	  The	  regression	  was	  statistically	  significant,	  r=.343,	  r2=.117,	  F(81)=10.638,	  p=.002.	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  Figure	  5:	  SLUMS	  score	  is	  positively	  correlated	  to	  serum	  albumin	  levels.	  	  	  
Red	  Blood	  Cell	  Count	  	  
	   To	  evaluate	  whether	  SLUMS	  score	  could	  be	  predicted	  by	  red	  blood	  cell	  count,	  a	  bivariate	  linear	  regression	  analysis	  was	  performed.	  Scores	  for	  both	  the	  SLUMS	  score	  and	  red	  blood	  cell	  count	  (red	  blood	  cells	  per	  liter)	  were	  approximately	  normally	  distributed	  with	  no	  extreme	  outliers.	  A	  scatter	  plot	  indicated	  the	  relation	  between	  X	  and	  Y	  was	  negative	  and	  there	  were	  no	  extreme	  bivariate	  outliers.	  The	  regression	  was	  statistically	  significant,	  r=.264,	  r2=.070,	  F(76)=5.626,	  p=.02.	  	  
DEMENTIA	  AND	  PRIMARY-­‐CARE	  HEALTH	  MEASURES	   	  	   17	  
	  Figure	  6:	  SLUMS	  score	  is	  positively	  correlated	  to	  red	  blood	  cell	  count.	  	  	  
Multiple	  Linear	  Regression	  Analysis	  
	   A	  multiple	  linear	  regression	  analysis	  was	  performed	  for	  the	  predictors	  of	  white	  blood	  cell	  count,	  serum	  albumin,	  red	  blood	  cell	  count,	  age	  and	  sex.	  Age	  and	  sex	  were	  not	  significant	  predictors	  of	  SLUMS	  score.	  The	  overall	  regression	  including	  the	  predictors	  of	  white	  blood	  cell	  count,	  serum	  albumin,	  red	  blood	  cell	  count,	  age,	  and	  sex	  was	  statistically	  significant,	  R=.535,	  R2=.286,	  F(5,73)=5.44,	  p<.001.	  	  	   A	  second	  linear	  analysis	  was	  also	  performed	  for	  the	  predictors	  of	  hearing,	  gait,	  age	  and	  sex.	  Sex	  was	  not	  a	  significant	  predictor	  of	  sex.	  The	  overall	  regression	  including	  the	  predictors	  of	  hearing,	  gait,	  age	  and	  sex	  was	  statistically	  significant,	  R=.685,	  R2=.410,	  F(4,40)=7.961,	  p<.001.	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Discussion	  
	   The	  results	  of	  this	  study	  show	  an	  association	  between	  scores	  on	  the	  SLUMS	  screening	  exam	  and	  hearing	  loss,	  abnormal	  gait,	  white	  blood	  cell	  count,	  serum	  albumin	  levels,	  and	  red	  blood	  cell	  count.	  The	  associations	  were	  also	  still	  significant	  when	  controlling	  for	  age	  and	  gender,	  indicating	  that	  the	  effects	  seen	  were	  not	  part	  of	  the	  normal	  aging	  process	  but	  are	  associated	  with	  cognitive	  impairment	  more	  severe	  than	  the	  effects	  of	  normal	  aging.	  	  	  	   The	  results	  were	  consistent	  with	  previous	  research.	  Patients	  with	  hearing	  loss	  in	  both	  ears	  had	  a	  mean	  SLUMS	  exam	  score	  lower	  than	  patients	  with	  hearing	  loss	  in	  one	  or	  neither	  ear.	  This	  supports	  previous	  research	  that	  found	  a	  negative	  association	  between	  hearing	  loss	  and	  score	  on	  the	  MMSE.	  Patients	  with	  abnormal	  gait	  had	  a	  mean	  SLUMS	  exam	  score	  lower	  than	  patients	  with	  normal	  gait,	  supporting	  previous	  research	  that	  found	  gait	  to	  be	  a	  predictor	  of	  non-­‐Alzheimer’s	  dementia.	  As	  this	  study	  did	  not	  consider	  clinical	  diagnoses,	  it	  suggests	  that	  abnormal	  gait	  is	  associated	  with	  greater	  cognitive	  impairment	  than	  normal	  gait,	  which	  suggests	  a	  more	  broad	  association	  than	  non-­‐Alzheimer’s	  dementia.	  	   White	  blood	  cell	  count	  and	  serum	  albumin	  level	  have	  been	  shown	  to	  be	  reliable	  predictors	  of	  systemic	  inflammation.	  In	  this	  study,	  high	  counts	  of	  white	  blood	  cells	  and	  low	  levels	  of	  serum	  albumin,	  both	  of	  which	  are	  indicative	  of	  inflammation,	  were	  associated	  with	  poorer	  scores	  on	  the	  SLUMS	  screening	  exam.	  This	  supports	  previous	  studies	  that	  examined	  the	  relationship	  between	  dementia	  and	  inflammation	  using	  markers	  of	  inflammation	  such	  as	  c-­‐reactive	  protein	  and	  interleukin-­‐6.	  	  If	  the	  same	  results	  can	  be	  predicted	  by	  white	  blood	  cell	  count	  and	  serum	  albumin	  levels,	  it	  is	  of	  clinical	  significance,	  as	  in	  many	  doctor’s	  office	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  testing	  for	  CRP	  and	  IL-­‐6	  is	  not	  readily	  available,	  however	  blood	  tests	  are	  almost	  universally	  performed.	  	  	   Red	  blood	  cell	  count	  was	  positively	  correlated	  with	  SLUMS	  exam	  score.	  Patients	  with	  a	  low	  red	  blood	  cell	  count	  performed	  more	  poorly	  on	  the	  SLUMS	  exam.	  This	  is	  an	  important	  contribution	  to	  dementia	  research	  as	  very	  few	  studies	  have	  to	  this	  date	  been	  done	  that	  have	  examined	  this	  connection.	  It	  is	  an	  important	  connection	  to	  nutritional	  status,	  and	  low	  red	  blood	  cell	  count	  can	  also	  be	  a	  sign	  of	  anemia	  and	  poor	  oxygen	  delivery	  to	  the	  brain.	  	  	   In	  clinical	  applications,	  it	  is	  useful	  to	  have	  several	  different	  markers	  to	  use	  for	  determining	  diagnosis.	  This	  study	  suggests	  a	  tentative	  picture	  for	  diagnosis	  of	  dementia	  that	  includes	  considering	  cognitive	  abilities,	  physical	  abilities	  and	  biomarkers	  of	  the	  blood.	  Further	  research	  is	  needed	  to	  confirm	  these	  associations	  and	  determine	  if	  they	  change	  before	  or	  after	  cognitive	  symptoms	  begin	  to	  appear.	  However,	  this	  knowledge	  could	  be	  extremely	  useful	  to	  improve	  early	  diagnoses	  of	  dementia	  and	  other	  disorders	  associated	  with	  cognitive	  impairment	  in	  an	  elderly	  population.	  	  	   This	  study	  was	  limited	  by	  a	  small	  sample	  size	  from	  only	  one	  location,	  and	  it	  was	  simply	  a	  correlational	  study.	  It	  also	  did	  not	  control	  for	  factors	  such	  as	  medications	  and	  chronic	  health	  conditions.	  Future	  research	  could	  be	  improved	  by	  a	  larger,	  more	  diverse	  sample	  size,	  a	  longitudinal	  design,	  and	  controlling	  for	  potential	  confounding	  factors.	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